Oric Pharmaceuticals
ORIC
ORIC
129 hedge funds and large institutions have $612M invested in Oric Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
8.42% more ownership
Funds ownership: 98.98% → 107.4% (+8.4%)
6% more funds holding
Funds holding: 122 → 129 (+7)
14% less capital invested
Capital invested by funds: $715M → $612M (-$103M)
Holders
129
Holding in Top 10
5
Calls
$3.26M
Puts
$52K
Top Buyers
| 1 | +$5.85M | |
| 2 | +$5.09M | |
| 3 | +$3.48M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.42M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.45M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$2.15M | |
| 3 | -$2.05M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.47M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.22M |